MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Funding Opportunities: Pioneers, Architects & Consolidators
Funding: Strategic Corporate Investment & Corporate Venture Capital (CVC)
COSAT-Corporate Office of Science and Technology, J&J
Johnson & Johnson:Driving Forces
Parents
*Driving Forces: Biomateriels & Nanomedicine
*Driving Forces: Market Research, Intelligence, Analysis, Datapoints, Databases & Trends
*Driving Forces: Medical Devices & Technology (Trends)-Enterprise
*Driving Forces: Triple Helix _ Translation, Commercialization, Technology Transfer, SBIR/STTR, OTA, NonTraditional / New Business Models
*Organization: Johnson & Johnson (J&J)
COSAT-Corporate Office of Science and Technology, J&J
Organization & Developments: Johnson & Johnson (J&J)
Venture-Investment Strategies
Children
*Drug Eluting Stents (DES)
$6.3b R&D (2005)
47m uninsured (2005)
Biosurgicals:J&J
Consumer focus:Efficiency
Curt Selquist, Partner, Water Street, former Company Group Chairman, J&J Healthcare Systems
Drug & Device combinations:J&J
Evidence based medicine:J&J
Nanomedicine:J&J
Neurostimulation:J&J
Regulation
Rising costs
Stent Patent Suit-Johnson & Johnson
Jumps
*Architects: Surgical Technology_Cardiovascular, Cardiac & Cardiology Companies _ Stents
*Driving Forces: Schools_Academia, Elementary, Secondary, Colleges and Universities (Pioneering Research)
*Pioneers: Stroke
*Pioneers: Telemedicine, Mobile Health, mHealth & Remote Patient Monitoring (RPM)
Architects: Biomaterials, Tissue Engineering, 3D Bioprinting & Regenerative Medicine
Architects: Cardiovascular, Cardiac & Cardiology Companies
Consolidators: Biomaterials/Tissue Engineering/Regenerative Medicine
DARPA:FISST